Two Pandemics, Two Surveys in the United States and in Spain
Bibliographic Data
| ID | 11039136 |
|---|---|
| Authors | Miguel A Hernán (0000-0003-1619-8456, Miguel A. Hernán is with the departments of epidemiology and biostatistics of the Harvard T. H. Chan School of Public Health, Boston, MA. Raquel Yotti is with the Instituto de Salud Carlos III, Madrid, Spain.), Raquel Yotti (0000-0002-5551-7408, Miguel A. Hernán is with the departments of epidemiology and biostatistics of the Harvard T. H. Chan School of Public Health, Boston, MA. Raquel Yotti is with the Instituto de Salud Carlos III, Madrid, Spain.) |
| Year | 2021 |
| Volume | 111 |
| Issue | 3 |
| Pages | 414-415 |
| Publication date | 2021-03-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2020.306105 |
| PMID | 33566650 |
| OpenAlex | W3127890490 |
| Language | EN |
| Citations received | 2 |
| References cited | 3 |
For ENE-COVID, the first wave of data collection was completed in two weeks by mobilizing and training 4400 health professionals in more than 1400 primary care centers, as well as creating an information system capable of hosting up to 2000 concurrent users The preexistence of a health care system with clinical laboratories around the country, with coordination from the National Centre for Microbiology at the Instituto de Salud Carlos III, allowed rapid transport and analysis of more than 50000 blood samples The 1918 US survey data could only be used to estimate the case fatality risk-that is, the proportion of individuals with influenza symptoms who died during the course of the disease 2 By contrast, the 2020 Spanish serosurvey data could be used to also estimate the infection fatality risk-that is, the proportion of individuals infected with SARS-CoV-2 (regardless of symptoms) who died 3 While knowing the case fatality risk is important for clinical purposes, knowing the infection fatality risk in different population groups assists pandemic management: we have no control over who becomes symptomatic after infection, but we can adopt measures to prevent infection
2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19) · Disease · Environmental health · Geography · Infectious disease (medical specialty) · Outbreak · Pandemic · Political science · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) · Sociology · COVID-19 and healthcare impacts · COVID-19 Clinical Research Studies · COVID-19 epidemiological studies · Demography · Medicine · Virology
| Citations per year | 0.67 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |